Clinical Trial Update: Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence [Phase 3]

View source ↗

Summary

Phase 3 trial update for mecamylamine in depression with alcohol dependence; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence
• Major Depressive Disorder

Drugs mentioned

• Mecamylamine (mecamylamine)

Snippet

Sponsor: Yale University | Conditions: Alcohol Dependence, Depression | Phase 3 | Status: COMPLETED | Results posted: 2016-04-18